NEW YORK, Jan. 26 (GenomeWeb News) - Genaissance Pharmaceuticals has exclusively licensed commercial rights to a patent held by Vanderbilt University that it said would expand its ability to provide genetic tests for variants of cardiac ion-channel proteins involved in drug-induced cardiac arrhythmias.
...and receive Daily News bulletins.
Already have an account?Login Now.
A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.
Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.
NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.
In Science this week: environmental DNA can help in studies of marine animals, and more.